2 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Service d'aide à la décision clinique

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

Journal Français d'Ophtalmologie
Volume 41, n° 10
pages e499-e500 (décembre 2018)
Doi : 10.1016/j.jfo.2018.06.001
Posters de la SFO

Interêt de l’omalizumab dans le traitement de la kérato-conjonctivite vernale sévère. Quand une kérato-conjonctivite vernale résiste aux traitements classiques
Omalizumab for severe vernal keratoconjunctivitis

M. Callet , N. Stolowy , E. Zanin , D. Denis
 Service d’ophtalmologie, CHU Nord Chemin des Bourrely, 13015 Marseille, France 

Auteur correspondant.

 Cette lettre à l’éditeur est issue d’un e-poster présenté au congrès annuel de la Société Française d’Ophtalmologie.

© 2018  Published by Elsevier Masson SAS.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline
You can move this window by clicking on the headline